POC Study of Pipamperone Added to Stable Treatment With RIS or PAL in Chronic Schizophrenia

NCT01450514 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

7

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Schizophrenia
Schizoaffective Disorder

Interventions

DRUG: Pipamperone
DRUG: Placebo

Sponsor

PharmaNeuroBoost N.V.